Search Results - "Qin, LunXiu"

Refine Results
  1. 1

    Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti–Programmed Cell Death‐1 in HCC by Yi, Chenhe, Chen, Lirong, Lin, Zhifei, Liu, Lu, Shao, Weiqing, Zhang, Rui, Lin, Jing, Zhang, Jubo, Zhu, Wenwei, Jia, Huliang, Qin, Lunxiu, Lu, Lu, Chen, Jinhong

    Published in Hepatology (Baltimore, Md.) (01-11-2021)
    “…Background and Aims Recently, clinical trials of lenvatinib plus pembrolizumab in HCC have displayed an impressive objective response rate. This study aimed to…”
    Get full text
    Journal Article
  2. 2

    Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies by Qin, Lunxiu

    Published in Frontiers of medicine (01-03-2014)
    “…In this review, we summarize the novel findings from our series of studies on the leading metastasis- related gene, osteopontin (OPN). In our previous gene…”
    Get full text
    Journal Article
  3. 3

    Current landscape and perspective of oncolytic viruses and their combination therapies by Su, Yinghan, Su, Changqing, Qin, Lunxiu

    Published in Translational oncology (01-11-2022)
    “…•Oncolytic virotherapy has become an important branch of cancer immunotherapy in clinical practice.•Multiple viruses can be engineered to be OVs and armed with…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Lipid metabolism in cancer progression and therapeutic strategies by Fu, Yan, Zou, Tiantian, Shen, Xiaotian, Nelson, Peter J., Li, Jiahui, Wu, Chao, Yang, Jimeng, Zheng, Yan, Bruns, Christiane, Zhao, Yue, Qin, Lunxiu, Dong, Qiongzhu

    Published in MedComm (2020) (01-03-2021)
    “…Dysregulated lipid metabolism represents an important metabolic alteration in cancer. Fatty acids, cholesterol, and phospholipid are the three most prevalent…”
    Get full text
    Journal Article
  6. 6

    Regulation of Cellular Metabolism by Protein Lysine Acetylation by Zhao, Shimin, Xu, Wei, Jiang, Wenqing, Yu, Wei, Lin, Yan, Zhang, Tengfei, Yao, Jun, Zhou, Li, Zeng, Yaxue, Li, Hong, Li, Yixue, Shi, Jiong, An, Wenlin, Hancock, Susan M, He, Fuchu, Qin, Lunxiu, Chin, Jason, Yang, Pengyuan, Chen, Xian, Lei, Qunying, Xiong, Yue, Guan, Kun-Liang

    “…Protein lysine acetylation has emerged as a key posttranslational modification in cellular regulation, in particular through the modification of histones and…”
    Get full text
    Journal Article
  7. 7

    Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin by Min, Lihua, Ji, Yuan, Bakiri, Latifa, Qiu, Zhixin, Cen, Jin, Chen, Xiaotao, Chen, Lingli, Scheuch, Harald, Zheng, Hai, Qin, Lunxiu, Zatloukal, Kurt, Hui, Lijian, Wagner, Erwin F.

    Published in Nature cell biology (01-11-2012)
    “…Understanding stage-dependent oncogenic mechanisms is critical to develop not only targeted therapies, but also diagnostic markers and preventive strategies…”
    Get full text
    Journal Article
  8. 8

    EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma by Dong, Qiongzhu, Du, Yi, Li, Hui, Liu, Chunxiao, Wei, Yongkun, Chen, Mei-Kuang, Zhao, Xixi, Chu, Yu-Yi, Qiu, Yufan, Qin, Lunxiu, Yamaguchi, Hirohito, Hung, Mien-Chie

    Published in Cancer research (Chicago, Ill.) (15-02-2019)
    “…PARP1 inhibitors (PARPi) are currently used in the clinic for the treatment of ovarian and breast cancers, yet their therapeutic efficacy against…”
    Get full text
    Journal Article
  9. 9

    Elevated G6PD expression contributes to migration and invasion of hepatocellular carcinoma cells by inducing epithelial-mesenchymal transition by Lu, Ming, Lu, Lu, Dong, Qiongzhu, Yu, Guangyang, Chen, Jinhong, Qin, Lunxiu, Wang, Lianxin, Zhu, Wenwei, Jia, Huliang

    Published in Acta biochimica et biophysica Sinica (01-04-2018)
    “…Abstract Altered metabolism is one of the hallmarks of cancer cells. Pentose phosphate pathway (PPP) is a fundamental component of cellular metabolism…”
    Get full text
    Journal Article
  10. 10

    LncRNA PVT1 induces aggressive vasculogenic mimicry formation through activating the STAT3/Slug axis and epithelial-to-mesenchymal transition in gastric cancer by Zhao, Jing, Wu, Jing, Qin, Yunyun, Zhang, Wenhong, Huang, Guangjian, Qin, Lunxiu

    Published in Cellular oncology (Dordrecht) (01-10-2020)
    “…Purpose Vasculogenic mimicry (VM), a vessel-like network formed by highly aggressive tumor cells, plays an important role in accelerating cancer progression…”
    Get full text
    Journal Article
  11. 11

    Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer by Zheng, Yan, Wu, Chao, Yang, Jimeng, Zhao, Yue, Jia, Huliang, Xue, Min, Xu, Da, Yang, Feng, Fu, Deliang, Wang, Chaoqun, Hu, Beiyuan, Zhang, Ze, Li, Tianen, Yan, Shican, Wang, Xuan, Nelson, Peter J., Bruns, Christiane, Qin, Lunxiu, Dong, Qiongzhu

    Published in Signal transduction and targeted therapy (13-05-2020)
    “…Enolase 2 (ENO2) is a key glycolytic enzyme in the metabolic process of glycolysis, but its potential function in pancreatic ductal adenocarcinoma (PDAC) is…”
    Get full text
    Journal Article
  12. 12

    Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3 by Sun, Haoting, Wang, Chaoqun, Hu, Beiyuan, Gao, Xiaomei, Zou, Tiantian, Luo, Qin, Chen, Mo, Fu, Yan, Sheng, Yuanyuan, Zhang, Kaili, Zheng, Yan, Ren, Xudong, Yan, Shican, Geng, Yan, Yang, Luyu, Dong, Qiongzhu, Qin, Lunxiu

    Published in Signal transduction and targeted therapy (26-05-2021)
    “…Intercellular cross-talk plays important roles in cancer progression and metastasis. Yet how these cancer cells interact with each other is still largely…”
    Get full text
    Journal Article
  13. 13

    Liver X Receptor Agonism Sensitizes a Subset of Hepatocellular Carcinoma to Sorafenib by Dual-Inhibiting MET and EGFR by Shao, Weiqing, Zhu, Wenwei, Lin, Jing, Luo, Mengjun, Lin, Zhifei, Lu, Lu, Jia, Huliang, Qin, Lunxiu, Lu, Ming, Chen, Jinhong

    Published in Neoplasia (New York, N.Y.) (01-01-2020)
    “…Sorafenib is the first approved systemic therapy for advanced hepatocellular carcinoma (HCC) and is the first-line choice in clinic. Sustained activation of…”
    Get full text
    Journal Article
  14. 14

    Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner by Qin, Zhaoyu, Xiang, Chan, Zhong, Fan, Liu, Yang, Dong, Qiongzhu, Li, Kai, Shi, Wenhao, Ding, Chen, Qin, Lunxiu, He, Fuchu

    “…Metabolic reprogramming is one of the hallmarks of cancer cells. The pentose phosphate pathway (PPP), a branch of glycolysis, is an important metabolic pathway…”
    Get full text
    Journal Article
  15. 15

    miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma by Lian, Junwei, Jing, Ying, Dong, Qiongzhu, Huan, Lin, Chen, Di, Bao, Chunyang, Wang, Qifeng, Zhao, Fangyu, Li, Jinjun, Yao, Ming, Qin, Lunxiu, Liang, Linhui, He, Xianghuo

    Published in Oncotarget (19-01-2016)
    “…Metastasis is one of the causes of cancer death. Functions and mechanisms of microRNAs (miRNAs) involved in hepatocellular carcinoma (HCC) metastasis are…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways by Wang, Hao, Pan, Junjie, Barsky, Livnat, Jacob, Jule Caroline, Zheng, Yan, Gao, Chao, Wang, Shun, Zhu, Wenwei, Sun, Haoting, Lu, Lu, Jia, Huliang, Zhao, Yue, Bruns, Christiane, Vago, Razi, Dong, Qiongzhu, Qin, Lunxiu

    Published in Molecular biomedicine (30-01-2021)
    “…Metastasis is a major contributor to cancer-associated deaths. It involves complex interactions between primary tumorigenic sites and future metastatic sites…”
    Get full text
    Journal Article
  19. 19

    The m6A methylation landscape stratifies hepatocellular carcinoma into 3 subtypes with distinct metabolic characteristics by Shen, Xiaotian, Hu, Beiyuan, Xu, Jing, Qin, Wei, Fu, Yan, Wang, Shun, Dong, Qiongzhu, Qin, Lunxiu

    Published in Cancer biology & medicine (15-11-2020)
    “…Epigenetic aberration plays an important role in the development and progression of hepatocellular carcinoma (HCC). However, the alteration of RNA…”
    Get full text
    Journal Article
  20. 20

    CAV1 promotes HCC cell progression and metastasis through Wnt/β-catenin pathway by Yu, Hongxiu, Shen, Huali, Zhang, Yang, Zhong, Fan, Liu, Yinkun, Qin, Lunxiu, Yang, Pengyuan

    Published in PloS one (2014)
    “…Caveolin-1 (CAV1) has significant roles in many primary tumors and metastasis, despite the fact that malignant cells from different cancer types have different…”
    Get full text
    Journal Article